ArticleHeadache2021
Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.
Andreas Yiangou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papertrialcites it